TAMMY TAYLOR: Open Payments
NPI 1710285606 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 20 payments from 11 companies in 2025. Trend: 2023 $586 · 2024 $743 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $115 |
| ABBVIE INC. | 4 | $88 |
| Abbott Laboratories | 3 | $50 |
| Novo Nordisk Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Seqirus USA Inc | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
Products named: FARXIGA, VRAYLAR, Ozempic, Fluad, TRINTELLIX, Veozah, REXULTI, JARDIANCE.
Industry payments across TN — which companies pay providers there.
